Laekna Limited
Clinical trials sponsored by Laekna Limited, explained in plain language.
-
New injection LAE102 enters human safety trials for weight control
Disease control Recruiting nowThis early-stage study tests a new injection called LAE102 to see if it is safe and how the body processes it. The trial involves 160 healthy and overweight/obese adults aged 18 to 65. Researchers will monitor side effects and measure drug levels in the blood to gather initial sa…
Phase: PHASE1 • Sponsor: Laekna Limited • Aim: Disease control
Last updated May 26, 2026 11:26 UTC
-
New Weight-Loss drug candidate LAE103 enters early human safety trials
Symptom relief Recruiting nowThis early-stage study tests the safety and tolerability of an experimental drug called LAE103 in healthy overweight or obese adults, and also in healthy postmenopausal women. Researchers will give single or multiple doses to see how the body processes the drug and if it causes s…
Phase: PHASE1 • Sponsor: Laekna Limited • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC